Chemical
Cyclophosphamide
(2RS)-N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
CAS: 50-18-0
Formula: C7H15Cl2N2O2P
Specifications
Key details (from tblproducts)
| CAS | 50-18-0 |
| Category | API |
| Molecular formula | C7H15Cl2N2O2P |
| Molecular weight | 261.09 |
| IUPAC | (2RS)-N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide |
| Smileys | O=P1(N(CCCl)CCCl)OCCCN1 |
Supplier listings below are pulled from tblproductsupplier + tblsuppliers.
Suppliers
Suppliers offering this product
| Supplier | Country | Stock | Action |
|---|---|---|---|
| Clearsynth | India | In Stock | View |
| Alsachim | FRANCE | In Stock | View |
| archie chem | United Kingdom | In Stock | View |
| Aspen Biopharma Labs Pvt Ltd | INDIA | — | View |
| Attix Pharmaceuticals | Canada | In Stock | View |
| Chemigran | Singapore | In Stock | View |
| DC chemicals | CHINA | In Stock | View |
| Jai Radhe Sales | INDIA | In Stock | View |
| Parchem | United States | In Stock | View |
| Qmx Laboratories Limited | England | In Stock | View |
| SAURAV CHEMICALS LIMITED | INDIA | In Stock | View |
| Standardpharm | United States | In Stock | View |
| Tocris Bioscience | INDIA | In Stock | View |
| Aaron Chemicals LLC | United States | In Stock | View |
| ALISTER PHARMA CHEM PRIVATE LIMITED | India | — | View |
| Andard-Mount Company Limited | United Kingdom | — | View |
| Chemillennium International (H.K.) Ltd. | China | — | View |
| European Pharmacopoeia | FRANCE | In Stock | View |
| FIPHARM GROUP Co.,Ltd | China | In Stock | View |
| Iffect Chemphar Co., Ltd | China | — | View |
| Respect labs llp | India | In Stock | View |
| Scintel Pharmachem Pvt Ltd | India | In Stock | View |
| Skyrun Industrial Co., Ltd. | CHINA | In Stock | View |
| STELLAR CHEMICAL LABORATORIES PVT. LTD. | India | — | View |
| Sustainable Green Technologies | United States | — | View |
| SUZHOU SUNRAY PHARMACEUTICAL CO., Ltd. | China | — | View |
| SYNRYN | India | In Stock | View |
| VANNSH LIFE SCIENCES PVT LTD | India | — | View |